2-(3′-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities
- 1 October 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (19) , 4225-4231
Abstract
No abstract availableKeywords
Funding Information
- DBT
- NIH
This publication has 31 references indexed in Scilit:
- Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding ModeACS Medicinal Chemistry Letters, 2012
- Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazolesBioorganic & Medicinal Chemistry Letters, 2011
- Synthesis of Novel Indolyl-1,2,4-triazoles as Potent and Selective Anticancer AgentsChemical Biology & Drug Design, 2011
- Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazolesEuropean Journal of Medicinal Chemistry, 2010
- Total Synthesis and Biological Evaluation of Tubulysin U, Tubulysin V, and Their AnaloguesJournal of Medicinal Chemistry, 2008
- CamalexinPhytochemistry, 2007
- Antimicrobial Activity and Cytotoxicity of Bis(indole) Alkaloids from the Sponge Spongosorites sp.Biological and Pharmaceutical Bulletin, 2006
- Comparative Activities of β-Lactam Antibiotics and Quinolones for Invasive Streptococcus pneumoniae IsolatesChemotherapy, 2004
- Binding of anandamide to bovine serum albuminJournal of Lipid Research, 2003
- Topsentins, new toxic bis-indole alkaloids from the marine sponge TopsentiagenitrixCanadian Journal of Chemistry, 1987